U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07063212) titled 'A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)' on July 03.
Brief Summary: The purpose of this study to find out whether sacituzumab govitecan in combination with cetuximab is an effective and safe treatment approach for people with recurrent and/or metastatic head and neck squamous cell cancer (HNSCC).
Study Start Date: July 02
Study Type: INTERVENTIONAL
Condition:
Squamous Cell Carcinoma of Head and Neck
Sinus Cancer
Nasal Cavity Cancer
Oral Cavity Cancer
Oropharynx Cancer
Hypopharynx Cancer
Larynx Cancer
Oral Squamous Cell Carcinoma
Oropharynx Squamous ...